🔴 Vivani Medical is trading 5.7% down in pre-market — no clear company-specific catalyst identified

Vivani Medical is trading 5.7% down at $1.33 in pre-market after closing at $1.41 on August 10, 2026; no clear company-specific catalyst was identified for the decline.

• Recently completed dosing all 20 participants in its SLIM-1 Phase 1 trial; top-line data are expected in November 2026.
• Q2 2026 earnings are expected August 12; no earnings result or guidance change has been reported.